Vinckier, F
Gaillard, R
Palminteri, S
Rigoux, L
Salvador, A
Fornito, A
Adapa, R
Krebs, M O
Pessiglione, M
Fletcher, P C
Article History
Received: 21 October 2014
Revised: 28 March 2015
Accepted: 13 April 2015
First Online: 9 June 2015
Competing interests
: RG has received compensation as a member of the scientific advisory board of Janssen, Lundbeck, Roche, Takeda. He has served as consultant and/or speaker for Astra Zeneca, Pierre Fabre, Lilly, Otsuka, SANOFI, Servier and received compensation, and he has received research support from Servier. PCF has consulted for Glaxo SmithKline and Lundbeck and received compensation. MOK has received compensation as a member of the scientific advisory board of Roche. She has served as speaker for Janssen and received unrestricted support for conference organization from Janssen and Otsuka-Lunbeck, and she has been invited to scientific meetings by Lundbeck and Takeda. AS has consulted for Servier and received compensation. FV has served as speaker for Servier and received compensation.